Phaseline

Companies › Halozyme Therapeutics

Halozyme Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 5 registered trials: 4 Phase 2, 1 Phase 3; Neurology, Metabolic and endocrine, Oncology; next expected readout Mar 2028.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Testosterone Enanthate
Androgen Receptor agonist
ARPhase 3Hypogonadism, Male; Spinal Cord Injury; Prostate Cancer; Castration Resistant Metastatic Prostate Cancer …Mar 2028

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04460872Testosterone EnanthatePhase 2Spinal Cord InjuryNeurologyJan 2026
NCT06594926Testosterone EnanthatePhase 2Prostate CancerOncologyDec 2026
NCT04363164Testosterone EnanthatePhase 2Castration Resistant Metastatic Prostate CancerOncologyJul 2027
NCT03522064Testosterone EnanthatePhase 2Castration-resistant Prostate CancerOncologyDec 2027
NCT06689085Testosterone EnanthatePhase 3Hypogonadism, MaleMetabolic and endocrineMar 2028

From the company's SEC filings

Cash of $1.0bn on 2026-09-30; operating cash flow positive

Press releases filed as 8-K in the last year:

Agreements filed with the SEC (item 1.01), last two years

Specialist investors

Held by 3 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

AR (1)

Companies with the same targets

Johnson & Johnson (Janssen) Novartis Astellas Alessa Therapeutics Sun Pharmaceutical Industries Hansoh BioMedical R&D Company Merck & Co. (MSD) Bayer Qilu Pharmaceutical Aragon Pharmaceuticals

Companies built like this

Amneal Pharmaceuticals Aragon Pharmaceuticals REGENXBIO CG Oncology Spur Therapeutics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.